Anaplastic Lymphoma Kinase-Rearranged Chest Wall-Undifferentiated Small Round Cell Sarcoma With Massive Pleural Effusion and Rapid Progression: A Case With Autopsy Report [0.03%]
复发性胸壁未分化小圆细胞肉瘤伴巨乳糜胸——1例ALK重排患儿的尸检报告
Toshiki Amioka,Kaori Okayasu,Shoko Iwanaga et al.
Toshiki Amioka et al.
Chest wall sarcomas are rare and may exhibit aggressive behavior, posing diagnostic challenges-particularly in young adults. Although multidisciplinary treatments involving chemotherapy, radiotherapy, and surgery are recommended, prognosis ...
Case Reports
Thoracic cancer. 2025 Sep;16(17):e70160. DOI:10.1111/1759-7714.70160 2025
C-Arm Cone Beam CT-Guided Preoperative Microcoil Pulmonary Ground Glass Nodule Localization: Diagnostic and Surgical Advantage [0.03%]
C臂锥形束CT引导下术前微导管定位肺磨玻璃结节的诊断及手术优势分析
Carlo Altomare,Rebecca Casati,Giuseppina Pacella et al.
Carlo Altomare et al.
Objective: This study evaluates the effectiveness and safety of C-arm cone beam CT (CBCT)-guided microcoil localization combined with uniportal video-assisted thoracoscopic surgery (VATS) for the management of small, diff...
Advances in the Application of Three-Dimensional Reconstruction in Thoracic Surgery: A Comprehensive Review [0.03%]
胸部手术三维重建应用进展：全面回顾
Guihu Lin,Ruzhen Li,Xiao Li et al.
Guihu Lin et al.
This review presents a comprehensive overview of recent advancements and clinical applications of three-dimensional (3D) reconstruction technology in thoracic surgery, with a focus on lung cancer surgery. The widespread adoption of chest co...
Pure Red Cell Aplasia That Developed 13 Years After Thymoma Treatment: A Case Report and Literature Review [0.03%]
胸腺瘤治疗后13年发生纯红细胞再生障碍一例报告及文献复习
Kento Kono,Kazuhisa Nakashima,Yukari Tsubata et al.
Kento Kono et al.
A 47-year-old woman was diagnosed with invasive thymoma 13 years ago. She had undergone repeated surgeries, as well as chemotherapy and radiation therapy. Chemotherapy was discontinued after the patient developed normocytic anemia, which wa...
RETRACTION: LncRNA SNHG14 Contributes to the Progression of NSCLC Through miR-206/G6PD Pathway [0.03%]
撤稿：长链非编码RNA SNHG14通过miR-206/G6PD通路促进NSCLC进展
L. Zhao, X. Zhang, Y. Shi, and T. Teng, "LncRNA SNHG14 Contributes to the Progression of NSCLC Through miR-206/G6PD Pathway," Thoracic Cancer 11, no. 5 (2020): 1202-1210, https://doi.org/10.1111/1759-7714.13374. The above article, published...
Three-Year Follow-Up of the Phase II Trial for Resectable Non-Small-Cell Lung Cancer Treated With Perioperative Sintilimab and Neoadjuvant Anlotinib Plus Chemotherapy: TD-NeoFOUR Trial [0.03%]
特瑞普利单抗围手术期联合新辅助阿帕替尼和化疗治疗可切除非小细胞肺癌 II 期临床试验的 3 年随访：TD-NeoFOUR 研究
Zhiyuan Gao,Yajie Mao,Yichen Sun et al.
Zhiyuan Gao et al.
Background: Lung cancer is a leading cause of cancer-related deaths. Perioperative therapies, including neoadjuvant chemo-immunotherapy, have improved outcomes, but combining them with antiangiogenic drugs may offer furth...
Clinical Trial
Thoracic cancer. 2025 Aug;16(16):e70149. DOI:10.1111/1759-7714.70149 2025
Beatrice Leonardi,Gaetana Messina,Giuseppe Vicario et al.
Beatrice Leonardi et al.
Patients with advanced lung cancer are candidates for systemic therapies. In the context of improved tumor responses and prolonged survival periods, the treatment of tumor/therapy-related complications must be taken into account. Rescue sur...
Current Status and Influencing Factors of Decisional Conflict in Lung Cancer Patients Receiving Systemic Therapy: A Cross-Sectional Analysis [0.03%]
肺癌系统性治疗患者的决策冲突现状及影响因素分析：一项横断面研究
Weicai Su,Jinping Li,Minfeng Zhai et al.
Weicai Su et al.
Objective: To investigate the current status of decisional conflict in lung cancer patients receiving systemic therapy and to analyze its influencing factors, with the aim of providing a basis for developing decision supp...
Effects of Sarcopenia on the Outcomes and Safety of Chemoradiotherapy Followed by Durvalumab for the Treatment of Patients With Locally Advanced Non-Small Cell Lung Cancer [0.03%]
肌少症对局部晚期非小细胞肺癌患者同期放化疗序贯度伐利尤单抗治疗疗效和安全性的影响
Kentaro Tamura,Hidehito Horinouchi,Mototaka Miyake et al.
Kentaro Tamura et al.
Background: Sarcopenia is associated with poor outcomes of various cancers treated with immune checkpoint inhibitors. Durvalumab is the standard of care for patients with locally advanced (LA) non-small cell lung cancer (...